Selenium fails to protect NSCLC patients against second primary tumors

Selenium supplementation does not reduce the risk for second primary tumors in patients with resected non–small-cell lung cancer, researchers say.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news